ENACT - REACT COVID (microbiome signatures)
Title: Study of gut microbiome signatures in COVID-19.
Design: Longitudinal laboratory-based prospective study.
Registration Number: Verona cohort registered on ClinicalTrials.gov
Primary Objective: to assess changes in the gut microbiome composition over time according to disease severity and treatment.
Secondary Objective(s): to find markers of microbiome composition correlated to immunological markers of infections; to assess changes in microbiome according to coinfections.
Interested in collaboration? Contact: Elda Righi (firstname.lastname@example.org).